We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COWN
1826
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $483K | ﹤0.01% |
12,509
+580
| +5% | +$22.4K |
|
1827
eHealth
EHTH
$39.1M
| $482K | ﹤0.01% |
99,514
+88,913
| +839% | +$331K |
|
|
KBAL
1828
DELISTED
Kimball International
KBAL
| $481K | ﹤0.01% |
73,924
-123,822
| -63% | -$847K |
|
|
HTBK
1829
DELISTED
Heritage Commerce
HTBK
| $480K | ﹤0.01% |
36,907
-33,913
| -48% | -$456K |
|
1830
Southside Bancshares
SBSI
$970M
| $480K | ﹤0.01% |
13,330
+6,246
| +88% | +$222K |
|
1831
Zeta Global
ZETA
$7.18B
| $479K | ﹤0.01% |
58,652
-71,397
| -55% | -$579K |
|
|
VBTX
1832
DELISTED
Veritex Holdings
VBTX
| $479K | ﹤0.01% |
17,062
+2,469
| +17% | +$73.4K |
|
1833
Ameris Bancorp
ABCB
$5.92B
| $478K | ﹤0.01% |
+10,133
| New | +$507K |
|
1834
ADMA Biologics
ADMA
$2.2B
| $477K | ﹤0.01% |
122,851
+48,655
| +66% | +$150K |
|
1835
Diamondrock Hospitality Co
DRH
$2.47B
| $476K | ﹤0.01% |
58,148
+15,544
| +36% | +$135K |
|
1836
Essential Properties Realty Trust
EPRT
$6.53B
| $476K | ﹤0.01% |
20,282
-901
| -4% | -$19.6K |
|
1837
First Interstate BancSystem
FIBK
$3.63B
| $475K | ﹤0.01% |
+12,296
| New | +$520K |
|
1838
ARKO Corp
ARKO
$506M
| $474K | ﹤0.01% |
+54,781
| New | +$507K |
|
1839
Tenable Holdings
TENB
$4.16B
| $470K | ﹤0.01% |
12,307
-8,695
| -41% | -$319K |
|
1840
Wingstop
WING
$3.06B
| $469K | ﹤0.01% |
3,407
+30
| +0.9% | +$4.43K |
|
|
CIM
1841
Chimera Investment
CIM
$1,000M
| $469K | ﹤0.01% |
28,401
-2,189
| -7% | -$40.8K |
|
|
CSW
1842
CSW Industrials
CSW
$5.74B
| $468K | ﹤0.01% |
4,033
-56
| -1% | -$6.7K |
|
1843
Herbalife
HLF
$1.21B
| $465K | ﹤0.01% |
31,253
+186
| +0.6% | +$3.24K |
|
1844
Park National Corp
PRK
$3.69B
| $461K | ﹤0.01% |
3,276
+448
| +16% | +$63.1K |
|
1845
Progyny
PGNY
$2.04B
| $457K | ﹤0.01% |
14,732
-10,115
| -41% | -$366K |
|
1846
Quad
QUAD
$510M
| $454K | ﹤0.01% |
111,373
-141,762
| -56% | -$451K |
|
|
LTC
1847
LTC Properties
LTC
$2.05B
| $453K | ﹤0.01% |
12,760
-1,267
| -9% | -$48.2K |
|
1848
Franklin Electric
FELE
$4.75B
| $452K | ﹤0.01% |
5,662
+219
| +4% | +$18.1K |
|
1849
Pulmonx
LUNG
$101M
| $450K | ﹤0.01% |
+53,332
| New | +$507K |
|
1850
Protagonist Therapeutics
PTGX
$9.6B
| $447K | ﹤0.01% |
40,970
-73,718
| -64% | -$622K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.